InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register account icon
S&P 500
5,544.59
(
-0.78%
)
US TECH 100
19,231.20
(
-0.21%
)
Dow Jones
40,665.02
(
-1.29%
)
Brent Oil
83.98
(
-0.60%
)
Bitcoin
63,831.65
(
-0.40%
)
Post# of 12660
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

iwfal

Send PM Follow Ignore
Followers 75
Posts 4700
Boards Moderated 0
Alias Born 09/06/2003

iwfal

Member Level

Re: rancherho post# 5386

Friday, 02/15/2008 8:30:50 PM

Friday, February 15, 2008 8:30:50 PM

Post# of 12660
With due respect to your healthy and well deserved skepticism about biotech hype and obvious statistical expertise, I stand by my opinion that the identification of two antigens derived from metastatic AIPC cell lines that GVAX produces a strong antibody response to increased survival.

Why is GVAX different than GTOP, AGEN, ... all of which showed strong correlation between immune response and survival - but utterly failed their ph iii's.

Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next
Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up